Welcome to Nature’s Bioceuticals Online Store

Nature’s Bioceuticals to Showcase New Products At Premier Natural Products Trade Show

Cape Coral, FL- December 19, 2011   
Nature’s Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk - News) announced that it has decided to showcase its new products by exhibiting at the Natural Products Expo West trade show held in the Anaheim Convention Center on March 9-11, 2012.
Robert deZanger, CEO of Natures Bioceuticals stated “We feel that Expo West is one of the premier places to gain exposure and brand awareness for our new products. Over 58,000 people attend including the buyers for Natural Products Stores, Chain Pharmacies Independent Drug Stores, Alternative Healthcare Practitioners and Therapists, Brokers, Distributors, Importers, Exporters and others. As the worlds largest natural and organic product tradeshow it attracts corporate buyers from around the globe. Also, top press from national publications are also in attendance. We expect this trade show to produce a great deal of new business for the company as it is a unique opportunity to meet, greet and take orders from new customers”
About Nature’s Bioceuticals: Nature’s Bioceuticals develops and acquires the rights to natural medicine formulas that are geared towards treating specific medical conditions. These medicines are all natural and derived from botanicals and mineral bases. Nature’s Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and more importantly do not have the negative side effects usually associated with many of today’s prescribed drugs.
Nature’s line of natural medicines will be either sold as prescription drugs, if applied for by the company and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, commonly referred to as "DSHEA"
In addition to historical information, this release contains forward-looking statements. Mistral Ventures, Inc. and/or Nature’s Bioceuticals may, from time to time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements encompass Mistral Ventures, Inc. and/or Nature’s Bioceuticals beliefs, expectations, hopes, or intentions regarding future events. Words such as “expects,” “intends,” “believes,” “anticipates,” “should,” “likely,” and similar expressions identify forward-looking statements. All forward-looking statements included in this release are made as of the date hereof and are based on information available to the Company as of such date. Mistral Ventures, Inc. nor Nature’s Bioceuticals assume any obligation to update any forward-looking statement. Actual results will vary, and may vary materially, from those anticipated, estimated, projected or expected for a number of reasons, including, among others: further reviews of the Company’s financial statements by the Company and its Audit Committee; modification of the Company’s accounting practices; foreign business risks; industry cyclicality; fluctuations in customer demand and order pattern; changes in pricing and general economic conditions; as well as other risks that may be delineated from time to time or filed with the SEC.
Media Contact: Financial Insights
Phone Number: 888 656 3509
E-mail: investors@naturesbioceuticals.com